Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 4 | 42D7A | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | CX4HL | IM / RA |
Patient and guardian did not consent to vaccination but doses were administered. No physical symptoms or adverse reaction occurred. 02/27/2025 Phone follow-up: Patient believes they did not consent states they did not consent to vaccine.